Helicobacter pylori 感染对美酸性食道炎和潜在病原体的因果关系:孟德尔的随机化研究
Zhenghui Zhu1, Yanqing Yang1, Xu Han1
1Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Frontiers in immunology
|May 23, 2024
概括
基因预测的抗Helicobacter pylori IgG抗体水平显示出对eosinophilic食道炎 (EoE) 的保护作用. 这项孟德尔随机化研究表明,H. pylori IgG是减少EoE风险的因果因素,独立于炎症调解者.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 观察性研究表明,Helicobacter pylori (H. pylori) 感染和eosinophilic食道炎 (EoE) 之间存在联系.
- 在H. pylori感染和EoE之间的因果关系仍然未确立.
- 门德尔随机化 (MR) 分析用于调查潜在的因果关系.
研究的目的:
- 使用MR调查H. pylori感染和EoE之间的因果关系.
- 探索潜在的介导途径,包括炎症性细胞因子,在H. pylori-EoE关系中.
主要方法:
- 进行了单变量和多变量门德尔随机化 (MR) 分析.
- 使用两步式MR来评估炎症性细胞因子 (IL-4,IL-5,IL-13,IL-17,IFN-γ) 的作用.
- 为了获得可靠的结果,进行了反变量加权 (IVW) 方法和灵敏度分析.
主要成果:
- 基因预测的抗H. pyloriIgG抗体水平与EoE风险降低有关 (OR=0.325,P=0.004).
- 对于其他H. pylori抗体,没有发现显著的因果关联.
- 抗H.pyloriIgG对EoE的保护作用在多变量MR分析中持续存在,而炎症因素并没有介导这种作用.
结论:
- 抗H. pyloriIgG抗体被确定为唯一的因果因素,可以提供对EoE的保护.
- 炎症因素可能在调解保护性关联方面没有发挥显著作用.
- 这些发现有助于理解EoE的病原和病因学.
相关概念视频
01:30Peptic Ulcer Disease I: Introduction
163
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
163
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
570
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
570
01:17Gastritis-II: Pathophysiology
319
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
319
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
380
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
380
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
306
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
306
01:28Peptic Ulcer Disease II: Pathophysiology
390
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
390